Aucta Pharmaceuticals Announces Licensing of Vigabatrin for Oral Solution in China

Aucta Pharmaceuticals Announces Licensing of Lamotrigine New Drug Application

Aucta Receives its First Product Approval and Launches Vigabatrin for Oral Solution Under the Brand Name Vigadrone™

Aucta Pharmaceuticals and Oakrum Pharma Announce Product Development and Commercialization Partnership